Juan Serna, Raymond Khargi, Kavita Gupta, Christopher Connors, Susan Gong, Anna Ricapito, Blair Gallante, Manishkumar Patel, Seunghee Kim-Schulze, William Atallah, Natasha Kyprianou, Mantu Gupta
{"title":"微型经皮肾镜取石术对肾脏损伤小?","authors":"Juan Serna, Raymond Khargi, Kavita Gupta, Christopher Connors, Susan Gong, Anna Ricapito, Blair Gallante, Manishkumar Patel, Seunghee Kim-Schulze, William Atallah, Natasha Kyprianou, Mantu Gupta","doi":"10.1177/08927790251372581","DOIUrl":null,"url":null,"abstract":"<p><p><b><i>Background and Objectives:</i></b> Percutaneous nephrolithotomy (PCNL) technique trends have shifted toward smaller caliber access sheaths, leading to a varied array of miniPCNL (mPCNL) systems. Urinary biomarkers have been validated as noninvasive direct markers of renal cellular injury. Our objective was to assess changes in biomarkers levels in the perioperative setting, comparing mPCNL suction (s-mPCNL), non-suction (ns-mPCNL), and standard PCNL (sPCNL) systems. <b><i>Patients and Methods:</i></b> PCNL systems used were as follows: s-mPCNL single-step dilator (ClearPetra™, 18F), ns-mPCNL metallic dilator and sheath (Storz MIP-M, 17.5F), and sPCNL with balloon dilation (Nephromax, 24F). Urine samples were collected at three time points: preoperatively (V1), 1 hour postoperatively (V2), and 10 days postoperatively (V3). Samples were analyzed using enzyme-linked immunofluorescent assay for key biomarkers-kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and β2-microglobulin (β2M)-normalized to urine creatinine. The primary outcome was changes in urinary biomarkers. <b><i>Results:</i></b> Twenty patients were randomized into two groups: s-mPCNL and ns-mPCNL, and 10 patients were assigned to the sPCNL cohort. The mean differences and percent change in biomarker levels at different time intervals were calculated as follows: early injury (V1-V2), recovery (V2-V3), and long-term injury (V1-V3). There was a statistically significant rise in NGAL levels for both ns-mPCNL and s-mPCNL in the early injury interval (2.377; <i>p</i> = 0.004, 2.606; <i>p</i> < 0.001, respectively), and a subsequent fall in levels during the recovery interval for sPCNL, ns-mPCNL, and s-mPCNL (-4.720; <i>p</i> = 0.026, -2.427; <i>p</i> = 0.014, -3.141; <i>p</i> = 0.018, respectively). There was no statistically significant difference in all three biomarkers for all forms of PCNL in the long-term injury interval. <b><i>Conclusion:</i></b> There is a sharp rise in urinary biomarkers in the immediate postoperative setting, likely because of early tubular injury, more notable in ns-mPCNL systems that utilize metal sheaths. However, this is a transient effect that normalizes days later irrespective of the sheath size used during the PCNL.</p>","PeriodicalId":15723,"journal":{"name":"Journal of endourology","volume":" ","pages":""},"PeriodicalIF":2.8000,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mini-Percutaneous Nephrolithotomy Less Injurious to the Kidney?\",\"authors\":\"Juan Serna, Raymond Khargi, Kavita Gupta, Christopher Connors, Susan Gong, Anna Ricapito, Blair Gallante, Manishkumar Patel, Seunghee Kim-Schulze, William Atallah, Natasha Kyprianou, Mantu Gupta\",\"doi\":\"10.1177/08927790251372581\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b><i>Background and Objectives:</i></b> Percutaneous nephrolithotomy (PCNL) technique trends have shifted toward smaller caliber access sheaths, leading to a varied array of miniPCNL (mPCNL) systems. Urinary biomarkers have been validated as noninvasive direct markers of renal cellular injury. Our objective was to assess changes in biomarkers levels in the perioperative setting, comparing mPCNL suction (s-mPCNL), non-suction (ns-mPCNL), and standard PCNL (sPCNL) systems. <b><i>Patients and Methods:</i></b> PCNL systems used were as follows: s-mPCNL single-step dilator (ClearPetra™, 18F), ns-mPCNL metallic dilator and sheath (Storz MIP-M, 17.5F), and sPCNL with balloon dilation (Nephromax, 24F). Urine samples were collected at three time points: preoperatively (V1), 1 hour postoperatively (V2), and 10 days postoperatively (V3). Samples were analyzed using enzyme-linked immunofluorescent assay for key biomarkers-kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and β2-microglobulin (β2M)-normalized to urine creatinine. The primary outcome was changes in urinary biomarkers. <b><i>Results:</i></b> Twenty patients were randomized into two groups: s-mPCNL and ns-mPCNL, and 10 patients were assigned to the sPCNL cohort. The mean differences and percent change in biomarker levels at different time intervals were calculated as follows: early injury (V1-V2), recovery (V2-V3), and long-term injury (V1-V3). There was a statistically significant rise in NGAL levels for both ns-mPCNL and s-mPCNL in the early injury interval (2.377; <i>p</i> = 0.004, 2.606; <i>p</i> < 0.001, respectively), and a subsequent fall in levels during the recovery interval for sPCNL, ns-mPCNL, and s-mPCNL (-4.720; <i>p</i> = 0.026, -2.427; <i>p</i> = 0.014, -3.141; <i>p</i> = 0.018, respectively). There was no statistically significant difference in all three biomarkers for all forms of PCNL in the long-term injury interval. <b><i>Conclusion:</i></b> There is a sharp rise in urinary biomarkers in the immediate postoperative setting, likely because of early tubular injury, more notable in ns-mPCNL systems that utilize metal sheaths. However, this is a transient effect that normalizes days later irrespective of the sheath size used during the PCNL.</p>\",\"PeriodicalId\":15723,\"journal\":{\"name\":\"Journal of endourology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.8000,\"publicationDate\":\"2025-09-03\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of endourology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1177/08927790251372581\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"UROLOGY & NEPHROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of endourology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/08927790251372581","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0
摘要
背景和目的:经皮肾镜取石术(PCNL)技术的趋势已经转向更小口径的导管套,导致各种各样的miniPCNL (mPCNL)系统。尿液生物标志物已被证实是肾细胞损伤的无创直接标志物。我们的目的是评估围手术期生物标志物水平的变化,比较mPCNL抽吸(s-mPCNL)、非抽吸(ns-mPCNL)和标准PCNL (sPCNL)系统。患者和方法:使用的PCNL系统如下:s-mPCNL单步扩张器(ClearPetra™,18F), ns-mPCNL金属扩张器和鞘(Storz MIP-M, 17.5F), sPCNL伴球囊扩张(Nephromax, 24F)。于术前(V1)、术后1小时(V2)、术后10天(V3)三个时间点采集尿样。采用酶联免疫荧光法分析样品的关键生物标志物-肾损伤分子-1 (KIM-1)、中性粒细胞明胶酶相关脂钙蛋白(NGAL)和β2微球蛋白(β2M)-与尿肌酐归一化。主要结局是尿液生物标志物的变化。结果:20例患者随机分为s-mPCNL和ns-mPCNL两组,其中10例患者被分配到sPCNL队列。生物标志物水平在不同时间间隔的平均差异和百分比变化计算如下:早期损伤(V1-V2),恢复(V2-V3)和长期损伤(V1-V3)。ns-mPCNL和s-mPCNL的NGAL水平在损伤早期均有统计学意义的升高(2.377,p = 0.004, 2.606, p < 0.001),而在恢复期sPCNL、ns-mPCNL和s-mPCNL的NGAL水平下降(-4.720,p = 0.026, -2.427, p = 0.014, -3.141, p = 0.018)。在长期损伤期间,所有形式PCNL的所有三种生物标志物均无统计学差异。结论:泌尿生物标志物在术后立即出现急剧上升,可能是由于早期小管损伤,在使用金属护套的ns-mPCNL系统中更为明显。然而,无论在PCNL期间使用的护套尺寸如何,这都是一种短暂的效应,几天后就会恢复正常。
Mini-Percutaneous Nephrolithotomy Less Injurious to the Kidney?
Background and Objectives: Percutaneous nephrolithotomy (PCNL) technique trends have shifted toward smaller caliber access sheaths, leading to a varied array of miniPCNL (mPCNL) systems. Urinary biomarkers have been validated as noninvasive direct markers of renal cellular injury. Our objective was to assess changes in biomarkers levels in the perioperative setting, comparing mPCNL suction (s-mPCNL), non-suction (ns-mPCNL), and standard PCNL (sPCNL) systems. Patients and Methods: PCNL systems used were as follows: s-mPCNL single-step dilator (ClearPetra™, 18F), ns-mPCNL metallic dilator and sheath (Storz MIP-M, 17.5F), and sPCNL with balloon dilation (Nephromax, 24F). Urine samples were collected at three time points: preoperatively (V1), 1 hour postoperatively (V2), and 10 days postoperatively (V3). Samples were analyzed using enzyme-linked immunofluorescent assay for key biomarkers-kidney injury molecule-1 (KIM-1), neutrophil gelatinase-associated lipocalin (NGAL), and β2-microglobulin (β2M)-normalized to urine creatinine. The primary outcome was changes in urinary biomarkers. Results: Twenty patients were randomized into two groups: s-mPCNL and ns-mPCNL, and 10 patients were assigned to the sPCNL cohort. The mean differences and percent change in biomarker levels at different time intervals were calculated as follows: early injury (V1-V2), recovery (V2-V3), and long-term injury (V1-V3). There was a statistically significant rise in NGAL levels for both ns-mPCNL and s-mPCNL in the early injury interval (2.377; p = 0.004, 2.606; p < 0.001, respectively), and a subsequent fall in levels during the recovery interval for sPCNL, ns-mPCNL, and s-mPCNL (-4.720; p = 0.026, -2.427; p = 0.014, -3.141; p = 0.018, respectively). There was no statistically significant difference in all three biomarkers for all forms of PCNL in the long-term injury interval. Conclusion: There is a sharp rise in urinary biomarkers in the immediate postoperative setting, likely because of early tubular injury, more notable in ns-mPCNL systems that utilize metal sheaths. However, this is a transient effect that normalizes days later irrespective of the sheath size used during the PCNL.
期刊介绍:
Journal of Endourology, JE Case Reports, and Videourology are the leading peer-reviewed journal, case reports publication, and innovative videojournal companion covering all aspects of minimally invasive urology research, applications, and clinical outcomes.
The leading journal of minimally invasive urology for over 30 years, Journal of Endourology is the essential publication for practicing surgeons who want to keep up with the latest surgical technologies in endoscopic, laparoscopic, robotic, and image-guided procedures as they apply to benign and malignant diseases of the genitourinary tract. This flagship journal includes the companion videojournal Videourology™ with every subscription. While Journal of Endourology remains focused on publishing rigorously peer reviewed articles, Videourology accepts original videos containing material that has not been reported elsewhere, except in the form of an abstract or a conference presentation.
Journal of Endourology coverage includes:
The latest laparoscopic, robotic, endoscopic, and image-guided techniques for treating both benign and malignant conditions
Pioneering research articles
Controversial cases in endourology
Techniques in endourology with accompanying videos
Reviews and epochs in endourology
Endourology survey section of endourology relevant manuscripts published in other journals.